Nephros, Inc.NEPHNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR+46.1%
5Y CAGR+24.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+46.1%/yr
vs -37.8%/yr prior
5Y CAGR
+24.9%/yr
Recent acceleration
Acceleration
+83.9pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 17.25% |
| 2024 | -13.86% |
| 2023 | 17.36% |
| 2022 | 5.53% |
| 2021 | 11.27% |
| 2020 | 5.67% |
| 2019 | 35.47% |
| 2018 | 36.96% |
| 2017 | 15.56% |
| 2016 | -17.11% |